Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Director Dealing

23 Dec 2016 07:00

RNS Number : 6712S
WANdisco Plc
23 December 2016
 

For immediate release

23 December 2016

 

WANdisco plc

("WANdisco" or the "Company")

 

Director Dealing

 

The Company was notified yesterday that David Richards, Chief Executive and Interim Chairman of WANdisco, sold 145,000 shares at a price of 200 pence per share on 22 December 2016. As a result the beneficial holding of David Richards is 2,638,153 Ordinary Shares representing approximately 7.1% of the Company's issued share capital of 37,002,330 Ordinary Shares

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

David Richards

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive and Interim Chairman

 

b)

 

Initial notification /Amendment

 

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

WANdisco plc

b)

 

LEI

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

 

 

Identification code

JE00BYPG6G89

 

 

b)

 

Nature of the transaction

 

Sale of shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

200 pence

145,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

145,000

 

 

- Price

200 pence

 

 

e)

 

Date of the transaction

 

22 December 2016

f)

 

Place of the transaction

 

London Stock Exchange

 

 

For further information, please contact:

 

WANdisco plc

via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

 

Erik Miller, Chief Financial Officer

 

 

 

Vigo Communications

+44 (0)207 830 9700

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

 

 

 

Stifel (Joint Broker and Nomad)

+44 (0)207 710 7600

David Arch / Fred Walsh / Neil Shah

 

 

 

UBS (Joint Broker)

Rahul Luthra / Sandip Dhillon

+44 (0)207 567 8000

 

About WANdisco

WANdisco (LSE: WAND) is the world leader in Active Transactional Data Replication™. Its patented technology provides continuous consistent access to changing data anytime and anywhere with no downtime and no disruption. WANdisco's patented technology serves crucial high availability (HA) requirements, including migration to cloud, Hadoop Big Data and Application Lifecycle Management (ALM), Subversion, Git and Gerrit.

 

WANdisco works directly with Fortune 1000 companies around the world and in all sectors to ensure their data, whether it is on-premise or in the cloud, gives them the real insight they need. WANdisco has an OEM with IBM and is also partnered with Amazon Web Services, Cisco, Google Cloud Platform, Hewlett Packard Enterprise, Microsoft Azure and Oracle to resell its patented technology. WANdisco is committed to the ODPi Interoperable Compliance Program to ensure its products are interoperable across a wider range of commercial Apache™ Hadoop® Platforms.

 

For additional information, please visit www.wandisco.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGGRPPUPQPGP
Date   Source Headline
27th Feb 20197:00 amRNSHolding(s) in Company
20th Feb 20192:42 pmRNSHolding(s) in Company
15th Feb 20193:11 pmRNSHolding(s) in Company
14th Feb 20197:00 amRNSAdvanced Technology Partner status with AWS
14th Feb 20197:00 amRNSSubscription for shares raising $17.5m
1st Feb 20197:00 amRNSTotal Voting Rights
10th Jan 20199:02 amRNSTotal Voting Rights
9th Jan 20194:35 pmRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSSQL product launch with IBM
3rd Jan 20197:00 amRNSInaugural Multi-Cloud Contract Win
27th Dec 20187:00 amRNSHealthcare Contract Win
13th Dec 20187:00 amRNSSignificant health insurance contract win
10th Dec 20187:00 amRNSDirector Dealings and Issue of Equity
3rd Dec 20187:00 amRNSBlock admission notification
3rd Dec 20187:00 amRNSTotal Voting Rights
19th Nov 20187:00 amRNSHire of SVP of marketing
19th Nov 20187:00 amRNSBoard change
7th Nov 201810:29 amRNSTotal Voting Rights
5th Nov 20187:00 amRNSContract win
31st Oct 20187:00 amRNSDirector Dealings
24th Oct 201811:11 amRNSDirector Dealings and Issue of Equity
17th Oct 20187:00 amRNSWANdisco launches LiveData for Multicloud
16th Oct 20189:32 amRNSDirector Dealings and Issue of Equity
12th Oct 20187:00 amRNSDirector/PDMR Shareholding
3rd Oct 20185:34 pmRNSDirector Dealings and Issue of Equity
2nd Oct 20188:27 amRNSTotal Voting Rights
25th Sep 20187:01 amRNSAutomotive contract win
25th Sep 20187:00 amRNSHalf-year Report
3rd Sep 20187:30 amRNSTotal Voting Rights
3rd Sep 20187:00 amRNSWANdisco plc Trading Update
1st Aug 20187:00 amRNSWANdisco's Total Voting Rights
25th Jul 20187:00 amRNSNew blockchain patent filing and VP of Engineering
3rd Jul 20189:00 amRNSWANdisco Total Voting Rights
29th May 20184:55 pmRNSBlock Listing Six Monthly Return
23rd May 201811:27 amRNSResult of AGM
22nd May 201812:05 pmRNSHolding(s) in Company
2nd May 20186:19 pmRNSTotal Voting Rights
25th Apr 20182:54 pmRNSHolding(s) in Company
16th Apr 20184:02 pmRNSHolding(s) in Company
4th Apr 20183:11 pmRNSHolding(s) in Company
3rd Apr 20184:56 pmRNSTotal Voting Rights
27th Mar 20181:44 pmRNSHolding(s) in Company
14th Mar 20187:00 amRNSDirector/PDMR Dealing
12th Mar 20187:00 amRNSWANdisco announces Co-Sell status with Microsoft
7th Mar 20187:00 amRNSAppointment of Joint Corporate Broker
7th Mar 20187:00 amRNSOEM SALES PARTNERSHIP WITH ALIBABA CLOUD
7th Mar 20187:00 amRNSPreliminary Results
2nd Mar 20187:18 amRNSTotal Voting Rights
26th Feb 201810:02 amRNSNotice of Results
1st Feb 20185:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.